Abstract
The vitrification of the antiferroelectric hexatic smectic XA* phase and cold crystallization are reported for (S)-4′-(1-methylheptylcarbonyl)biphenyl-4-yl 4-[5-(2,2,3,3,4,4,4-heptafluorobutoxy) heptyl-1-oxy]benzoate. The kinetics of isothermal cold crystallization and melt crystallization are investigated, revealing that both are controlled mainly by diffusion, as indicated by decrease in the characteristic crystallization time with increasing temperature of crystallization, with an activation energy of 114 kJ/mol. A weak relaxation process is detected in a crystal phase, with an activation energy of 38 kJ/mol, implying the conformationally disordered crystal phase. The estimated fragility parameter of the investigated glass former is equal to 94.5, which indicates rather high fragility.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
